Supplementary Figure 1 from Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Autor: Jennifer R. Grandis, Jill M. Siegfried, Marina N. Nikiforova, Lori Wirth, Athanassios Argiris, Seungwon Kim, Jonas T. Johnson, Robert L. Ferris, Thomas P. Conrads, Mai Sun, Melanie S. Flint, Brian L. Hood, Simion Chiosea, Lin Wang, Sufi M. Thomas, William Denq, William E. Gooding, Julie E. Bauman, Neil D. Gross
Rok vydání: 2023
DOI: 10.1158/1078-0432.22457436.v1
Popis: PDF file - 176KB, Assessing the Adequacy of Randomization.
Databáze: OpenAIRE